Related references
Note: Only part of the references are listed.Dose-Effect Relationships of 166Ho Radioembolization in Colorectal Cancer
Caren van Roekel et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Gamma camera characterization at high holmium-166 activity in liver radioembolization
Martina Stella et al.
EJNMMI PHYSICS (2021)
Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization-a prospective, within-patient randomized study
Caren van Roekel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases
Maarten L. J. Smits et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
First Evidence for a Dose-Response Relationship in Patients Treated with 166Ho Radioembolization: A Prospective Study
Remco Bastiaannet et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Renal and Intestinal Excretion of 90Y and 166Ho After Transarterial Radioembolization of Liver Tumors
Robert Drescher et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study
Arthur J. A. T. Braat et al.
LANCET ONCOLOGY (2020)
Simultaneous Ho-166/Tc-99m dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization
R. van Rooij et al.
EJNMMI PHYSICS (2020)
Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible
M. Stella et al.
EJNMMI PHYSICS (2020)
Evaluation of the Safety and Feasibility of Same-Day Holmium-166-Radioembolization Simulation and Treatment of Hepatic Metastases
Caren van Roekel et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Holmium-166 Microsphere Radioembolization of Hepatic Malignancies
Margot T. M. Reinders et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(L-lactic acid) microspheres
Robbert C. Bakker et al.
NUCLEAR MEDICINE AND BIOLOGY (2019)
Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice
Christoph G. Radosa et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study
Arthur J. A. T. Braat et al.
EUROPEAN RADIOLOGY (2018)
Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study
Jip F. Prince et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types
Marnix G. E. H. Lam et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres
Mattijs Elschot et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Radiation Emission from Patients Treated with Holmium-166 Radioembolization
Jip F. Prince et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
Gerrit H. van de Maat et al.
EUROPEAN RADIOLOGY (2013)
In Vivo Dosimetry Based on SPECT and MR Imaging of 166Ho-Microspheres for Treatment of Liver Malignancies
Maarten L. J. Smits et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Quantification of holmium-166 loaded microspheres: Estimating high local concentrations using a conventional multiple gradient echo sequence with S0-fitting
Gerrit H. van de Maat et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
Maarten L. J. Smits et al.
LANCET ONCOLOGY (2012)
Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
Maarten L. J. Smits et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Factors affecting the sensitivity and detection limits of MRI, CT, and SPECT for Multimodal diagnostic and therapeutic agents
Peter R. Seevinck et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
Andrew Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Liver tumors: MR imaging of radioactive holmium microspheres - Phantom and rabbit study
JFW Nijsen et al.
RADIOLOGY (2004)
Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study
F Nijsen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Share Paper
